P McSweeney
Overview
Explore the profile of P McSweeney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laudenslager M, Simoneau T, Kilbourn K, Natvig C, Philips S, Spradley J, et al.
Bone Marrow Transplant
. 2015 May;
50(8):1110-8.
PMID: 25961767
Caregivers of patients receiving allogeneic hematopoietic stem cell transplants (allo-HSCT) serve a pivotal role in patient care but experience high stress, anxiety and depression as a result. We theorized that...
2.
Ostronoff F, Milano F, Gooley T, Gutman J, McSweeney P, Petersen F, et al.
Bone Marrow Transplant
. 2012 Dec;
48(6):782-6.
PMID: 23241738
Reduced-intensity conditioning (RIC) regimens in cord blood transplant (CBT) are increasingly utilized for older patients and those with comorbidities. However, the optimal conditioning regimen has not yet been established and...
3.
Shaughnessy P, Uberti J, Devine S, Maziarz R, Vose J, Micallef I, et al.
Bone Marrow Transplant
. 2012 Nov;
48(6):777-81.
PMID: 23178544
Before US regulatory approval, an expanded access program provided plerixafor to patients with non-Hodgkin's lymphoma (NHL), Hodgkin's lymphoma (HD) or multiple myeloma (MM) who had not previously failed mobilization and...
4.
Miller C, Waller E, Klingemann H, Dignani M, Anaissie E, Cagnoni P, et al.
Bone Marrow Transplant
. 2004 Jan;
33(5):543-8.
PMID: 14730342
The current study assessed renal function based on medical records in adult hematopoietic stem cell transplant (HSCT) recipients with proven or probable invasive fungal infection (IFI) transplanted between 1995 and...
5.
McSweeney P
J Rheumatol Suppl
. 2001 Oct;
64:49-54.
PMID: 11642505
Recent studies have suggested limited efficacy of high dose cyclophosphamide and autologous stem cell transplant as a treatment for severe rheumatoid arthritis. Preclinical data and anecdotal evidence from human transplants...
6.
Binks M, Passweg J, Furst D, McSweeney P, Sullivan K, Besenthal C, et al.
Ann Rheum Dis
. 2001 May;
60(6):577-84.
PMID: 11350846
Background: Systemic sclerosis (SSc, scleroderma) in either its diffuse or limited skin forms has a high mortality when vital organs are affected. No treatment has been shown to influence the...
7.
Carnevale-Schianca F, MARTIN P, Sullivan K, Flowers M, Gooley T, Anasetti C, et al.
Biol Blood Marrow Transplant
. 2000 Dec;
6(6):613-20.
PMID: 11128811
Chronic graft-versus-host disease (GVHD) is the principal cause of transplantation-related morbidity and nonrelapse mortality late after allogeneic hematopoietic stem cell transplantation. The safety and potential efficacy of tacrolimus for the...
8.
Sandmaier B, McSweeney P, Yu C, Storb R
Semin Oncol
. 2000 Jul;
27(2 Suppl 5):78-81.
PMID: 10877058
Conditioning regimens have been intensified to a level at which organ toxicties are dose-limiting, which restricts the application of hematopoietic stem cell transplants to relatively young patients in otherwise good...
9.
Openshaw H, Stuve O, Antel J, Nash R, Lund B, Weiner L, et al.
Neurology
. 2000 Jun;
54(11):2147-50.
PMID: 10851379
Four of 10 patients who were enrolled on protocols of high-dose immunosuppression with peripheral blood stem cell rescue for MS experienced neurologic worsening while receiving recombinant human granulocyte colony-stimulating factor....
10.
Carella A, Champlin R, Slavin S, McSweeney P, Storb R
Bone Marrow Transplant
. 2000 Mar;
25(4):345-50.
PMID: 10723575
Conventional allogeneic stem cell transplantation is a valuable approach to therapy for many hematologic malignancies. However, high-dose conditioning regimens designed both to control the malignancy and to prevent graft rejection...